Philippine FDA announced FDA Circular No.2024-003 on March 26, 2024. This issuance extended the dates for the application of a CMDN and CMDR for all Class B, C and D medical device that are not included in the list of registrable medical devices based on FC No. 2020-001-A. All Class B, C and D medical devices that are not included in the list of registrable medical devices based on FC No. 2020-0..

On February 22, 2023, the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19) (the COVID-19 Medical Devices Regulations) came into force and created a permanent regulatory framework under Part 1.1 of the MDR for COVID-19 medical devices. Health Canada has expanded the scope of Part 1.1 f..

What is NOM (Norma Oficial Mexicana)? Mexico regulatory standards that manufacturers meet to protect the safety of medical device, IVD, and pharmaceutical users. Mexico COFEPRIS invalidated the standard NOM-137-SSA1-2008 on medical device labeling published in December 2008, and announced an updated new NOM for medical device labeling, NOM-137-SSA1-2024, on April 23, 2024. Updated NOM-137-SSA1-2..

NMPA announced “notice on improving cosmetics safety evaluation and management measures” on April 22, 2024 to further optimize cosmetics safety evaluation and management and to promote orderly implementation of the cosmetics safety evaluation system. This announcement will take effect from May 1, 2024. The contents of the notice, which will take effect from May 1, 2024, are as follows. 1. Classi..

The Ministry of Food and Drug Safety published ｢Guidelines for evaluating physical and chemical properties of non-absorbable polymer materials for biological safety evaluation of medical devices｣ on April 08, 2024 to help prepare biological evaluation data for medical devices by explaining the requirements, evaluation principles, and processes of data on physical and chemical characteristics ana..

The U.S. Food and Drug Administration published a draft guidance document on March 13, 2024, of Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act. FDA intends to incorporate the updates proposed in this draft guidance into the Premarket Cybersecurity Guidance as one final guidance document after obtaining and considering public comment on these proposed select..

On February 23, 2024, CDSCO(Central Drugs Standard Control Organization), through a circular, required all registered importers of cosmetic products in India to submit an annual declaration detailing the imported products from the date of approval of registration. Effective immediately from February 23, 2024, this directive is consistent with the regulations set out in the Cosmetics Rules 2020. ..

The CMDE under the National Medical Products Administration (NMPA) of China has issued guidelines for registration and review of high-frequency beauty devices (No. 8[2023]). Manufacturers of radio frequency beauty devices classified as Class III will have to comply with the new technical review guidelines from April 1, 2024. The High Frequency beauty device Registration and Review Guidelines (No..

On February 17, 2023, the NMPA in China made an announcement on the implementation of the 3rd Unique Device Identification (UDI) of medical devices. Depending on the degree of risk and regulatory needs, some Class2 medical devices, such as disposable products with high clinical demand, products selected for mass supply, and medical beauty-related products, are determined to be in the third batch..

FDA published a Quality Management System Regulation (QMSR) final rule on February 2, 2024 to revise the current good manufacturing practice (CGMP) requirements for medical devices in the Quality System (QS) Regulation (21 CFR Part 820). FDA amends Part 820 to incorporate the QMS requirements of ISO13485 as references. Replacing the Quality System(QS) with the Quality Management System Regulatio..